Palisade Bio (PALI) Income towards Parent Company (2010 - 2026)

Palisade Bio (PALI) has 17 years of Income towards Parent Company data on file, last reported at -$10.7 million in Q1 2026.

• On a quarterly basis, Income towards Parent Company fell 365.12% year-over-year to -$10.7 million in Q1 2026; TTM through Mar 2026 was -$26.5 million, a 96.1% decrease from a year earlier, with the FY2025 full-year figure at -$45.3 million, up 4.19% from the prior year.
• Income towards Parent Company for Q1 2026 stood at -$10.7 million, down from -$10.0 million in the prior quarter.
• Over the last five years, Income towards Parent Company for PALI reached as high as -$2.3 million in Q1 2025 and fell as low as -$38.2 million in Q1 2023.
• Historically, Income towards Parent Company has averaged -$6.4 million across 5 years, with a median of -$3.7 million in 2024.
• Across the five-year window, Income towards Parent Company tumbled 871.08% in 2023 and soared 90.34% in 2024, its largest moves.
• Year by year, Income towards Parent Company stood at -$3.9 million in 2022, then grew by 18.02% to -$3.2 million in 2023, then decreased by 7.29% to -$3.4 million in 2024, then plunged by 194.83% to -$10.0 million in 2025, then dropped by 7.64% to -$10.7 million in 2026.
• Per Business Quant data, the three most recent Income towards Parent Company figures were -$10.7 million in Q1 2026, -$10.0 million in Q4 2025, and -$2.9 million in Q3 2025.